Startup India Government of India
Advanced Transplant Diagnostics and Immunogenetics Private Limited
Advanced Transplant Diagnostics and Immunogenetics Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.72 Cr
▲ 15% YoY
Net profit · FY 2025
₹48.06 Lakh
Net margin 17.7%
EBITDA · FY 2025
₹1.01 Cr
EBITDA margin 37.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
5
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Advanced Transplant Diagnostics and Immunogenetics Private Limited
Data last updated:
Advanced Transplant Diagnostics and Immunogenetics Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 09 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U93090MH2019PTC330328.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bharat Vallabhdas Shah and Shruti Niranjan Tapiawala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 401 Rajveer Royals Next To Jyoti Dwelling Bld Ghatkopar Andheri Link Rd, Mumbai, Maharashtra, India – 400093.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.72 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹48.06 Lakh (net margin 17.7%) and EBITDA of ₹1.01 Cr (EBITDA margin 37.1%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years.
Company details
CIN U93090MH2019PTC330328
Registration Number 330328
Incorporation Date 09 September 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Bharat Vallabhdas Shah Director Shruti Niranjan Tapiawala Director Hepal Mihir Vora Director Recognitions & Rankings of Advanced Transplant Diagnostics and Immunogenetics
Contact details
Advanced Transplant Diagnostics and Immunogenetics Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address401 Rajveer Royals Next To Jyoti Dwelling Bld Ghatkopar Andheri Link Rd, Mumbai, Maharashtra, India – 400093
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Advanced Transplant Diagnostics and Immunogenetics Private Limited, buy the company report.
Comprehensive company report
Advanced Transplant Diagnostics and Immunogenetics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Advanced Transplant Diagnostics and Immunogenetics is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Advanced Transplant Diagnostics and Immunogenetics Private Limited, buy the company report.
Financials of Advanced Transplant Diagnostics and Immunogenetics Private Limited
FY 2025 filings availableAdvanced Transplant Diagnostics and Immunogenetics Private Limited reported revenue of ₹2.72 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹2.72 Cr ▲ 15%
Net profit · FY 2025
₹48.06 Lakh margin 17.7%
EBITDA · FY 2025
₹1.01 Cr margin 37.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 28% over three years, including 15% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.01 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.1% | ||||
| Net Profit Margin | 17.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Advanced Transplant Diagnostics and Immunogenetics Private Limited, buy the company report.
Board of directors of Advanced Transplant Diagnostics and Immunogenetics Private Limited
Advanced Transplant Diagnostics and Immunogenetics has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharat Vallabhdas Shah | Director | 09 Sep 2019 | 7 Years 1 Months | Current |
| Shruti Niranjan Tapiawala | Director | 09 Sep 2019 | 7 Years 1 Months | Current |
| Hepal Mihir Vora Also directs: Atdi Lab Private Limited, Atdi Sambhaji Nagar Lab Private Limited | Director | 06 Nov 2020 | 6 Years 0 Months | Current |
| Zaheer Aminmohamed Virani | Director | 06 Nov 2020 | 6 Years 0 Months | Current |
| Prashant Jayendrasingh Rajput | Director | 06 Nov 2020 | 6 Years 0 Months | Current |
Peer comparison
Advanced Transplant Diagnostics and Immunogenetics Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shanti Scan Centre Private Limited | ₹2.75 Cr (FY 2025) | 4.0% | Hooghly, West Bengal, India | |||
| Advanced Transplant Diagnostics and Immunogenetics Private Limitedthis company | ₹2.72 Cr (FY 2025) | ₹48.06 Lakh | 17.7% | 15.0% | Mumbai, Maharashtra, India | |
| Mukta Healthcare Private Limited | ₹2.7 Cr (FY 2025) | -6.0% | Siliguri, West Bengal, India | |||
| Agm Lab Private Limited | ₹2.69 Cr (FY 2025) | 257.0% | Raigarh, Chhattisgarh, India | |||
| DT Path Lab Private Limited | ₹2.67 Cr (FY 2025) | 38.0% | Kharar, Punjab, India |
To see the full peer comparison of Advanced Transplant Diagnostics and Immunogenetics Private Limited, buy the company report.
Auditor
Advanced Transplant Diagnostics and Immunogenetics Private Limited is audited by HDS & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HDS & ASSOCIATES LLP | FY 2023 | W100144 |
Shareholding
The shareholding of Advanced Transplant Diagnostics and Immunogenetics Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Advanced Transplant Diagnostics and Immunogenetics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Advanced Transplant Diagnostics and Immunogenetics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Advanced Transplant Diagnostics and Immunogenetics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Advanced Transplant Diagnostics and Immunogenetics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Advanced Transplant Diagnostics and Immunogenetics Private Limited has 8 board changes on record since 2019: 5 appointments and 3 cessations. The latest: Hepal Mihir Vora ceased to be Additional Director on 16 Aug 2022.
AGM
Advanced Transplant Diagnostics And Immunogenetics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Advanced Transplant Diagnostics And Immunogenetics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Hepal Mihir Vora ceased to be Additional Director.
Ceased
Prashant Jayendrasingh Rajput ceased to be Additional Director.
Ceased
Zaheer Aminmohamed Virani ceased to be Additional Director.
Appointed
Hepal Mihir Vora was appointed as Director.
Appointed
Prashant Jayendrasingh Rajput was appointed as Director.
Appointed
Zaheer Aminmohamed Virani was appointed as Director.
Appointed
Bharat Vallabhdas Shah was appointed as Director.
Appointed
Shruti Niranjan Tapiawala was appointed as Director.
Incorporation
09 Sep 2019
Advanced Transplant Diagnostics And Immunogenetics Private Limited was registered on 09 Sep 2019 with Roc Mumbai I & aged 7 years 1 month as per MCA records.
Frequently asked questions
Advanced Transplant Diagnostics and Immunogenetics is an active private limited company based in Mumbai, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 09 September 2019 (7+ years old) and is registered under CIN U93090MH2019PTC330328.
Advanced Transplant Diagnostics and Immunogenetics has 5 current directors:
- Bharat Vallabhdas Shah - Director
- Shruti Niranjan Tapiawala - Director
- Hepal Mihir Vora - Director
- Zaheer Aminmohamed Virani - Director
- Prashant Jayendrasingh Rajput - Director
The latest financial statements of Advanced Transplant Diagnostics and Immunogenetics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Advanced Transplant Diagnostics and Immunogenetics is U93090MH2019PTC330328. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Advanced Transplant Diagnostics and Immunogenetics was incorporated on 09 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Advanced Transplant Diagnostics and Immunogenetics by revenue are Shanti Scan Centre Private Limited, Mukta Healthcare Private Limited, Agm Lab Private Limited, DT Path Lab Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (human health activities).
Hepal Mihir Vora ceased to be Additional Director on 16 Aug 2022. Prashant Jayendrasingh Rajput ceased to be Additional Director on 16 Aug 2022. Zaheer Aminmohamed Virani ceased to be Additional Director on 16 Aug 2022. Advanced Transplant Diagnostics and Immunogenetics has 8 board changes on record in total.
Yes, Advanced Transplant Diagnostics and Immunogenetics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Advanced Transplant Diagnostics and Immunogenetics is at 401 Rajveer Royals Next To Jyoti Dwelling Bld Ghatkopar Andheri Link Rd, Mumbai, Maharashtra, India – 400093.
Advanced Transplant Diagnostics and Immunogenetics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Advanced Transplant Diagnostics and Immunogenetics can be reached at its registered office: 401 Rajveer Royals Next To Jyoti Dwelling Bld Ghatkopar Andheri Link Rd, Mumbai, Maharashtra, India – 400093.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages